Teleflex Incorporated Announces Worldwide Voluntary Recall of HUDSON RCI® SHERIDAN SHER-I-BRONCH® Endobronchial Tube
September 08 2015 - 9:00AM
Business Wire
Teleflex Incorporated (NYSE: TFX) announced today that the U.S.
Food and Drug Administration (FDA) has classified the voluntary
medical device recall of HUDSON RCI® SHERIDAN SHER-I-BRONCH®
Endobronchial Tube as a Class 1 recall. FDA defines Class I recalls
as, “a situation in which there is a reasonable probability that
the use of or exposure to a violative product will cause serious
adverse health consequences or death.”
Teleflex is recalling the products referenced above following
receipt of customer complaints reporting that the double swivel
connector may crack or separate on the endobronchial tube. Should
this occur, the device may leak, causing a risk of respiratory
distress or hypoxia that can, in some cases, lead to the need to
re-intubate the patient. There have been no reports of patient
injury as a result of this issue.
Teleflex notified both domestic and foreign hospitals and
distributors via an Urgent Medical Device recall letter dated June
1, 2015. This recall involves the retrieval of unused product in
the field.
At the time of the recall, there were 78 complaints of this
issue. Two-hundred thirty-three (233) lots across twelve (12)
product codes are affected by this recall for a total of 188,195
units distributed to the field. See table below for affected
product codes. A full list of affected lot numbers can be found in
the appendix to this notification.
PRODUCTS AFFECTED:
Product Codes
5-15401 5-16037 5-16128
5-16139 5-16028 5-16039
5-16135 5-16141 5-16035
5-16041 5-16137
5-16142
The original recall notice can be found at Teleflex’s
website:
http://www.teleflex.com/en/recall/Sheribronch%201st%20Customer%20Notification.pdf
Consumers with questions may contact the company at
1-866-246-6990; 8am to 8pm, ET, Monday through Friday.
Any adverse reactions experienced with the use of this product,
and/or quality problems can also be reported to the FDA’s MedWatch
Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by
mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD
20852-9787, or on the MedWatch website at www.fda.gov/medwatch.
Appendix
Material Number Batch
MaterialNumber
Batch
MaterialNumber
Batch 5-15401
01K1300254 5-16037
01K1300143 5-16039
73E1400114 01L1300393 01K1300144
73F1400353 01M1300212 01K1300346
73G1400256 01A1400436 01K1300347
73G1400377 01C1400086 01K1300579
73J1400398 73D1400096 01L1300081
73J1400408 73D1400496 01L1300280
73K1400463 73E1400269 01L1300281
73L1400196 73F1400153 01L1300384
73L1400097 73F1400352 01L1300558
73M1400194 73G1400052 01M1300074
73A1500483 73G1400288 01M1300117
73A1500484 73H1400331 01M1300213
73A1500591 73J1400401 01M1300313
73A1500592 73L1400106 01A1400121
73C1500112 73M1400208 01A1400194
73C1500113 73A1500345 01A1400433
73C1500258 73B1500272 01A1400575
73C1500259 73C1500255 01B1400084
01L1300385 5-16028 01L1300279
01B1400115 01A1400122 01A1400574
01B1400242 01C1400261 73D1400255
01C1400087 73E1400115 73F1400448
01C1400088 73G1400388 73J1400537
01C1400285 73J1400399 73A1500341
73D1400256 73A1500204 73C1500431
73D1400627 73B1500533 5-16035
01J1300471 73E1400270 73C1500583
01J1300472 73E1400366 01L1300155
01K1300050 73F1400189
01A1400453 01K1300073 73G1400053
5-16041 73L1400096 01K1300578
73G1400176 73B1500256 01L1300382
73H1400034 01C1400406 01L1300383
73H1400161 73D1400497 01L1300557
73H1400333 73F1400095 01M1300073
73H1400442 73J1400116 01M1300312
73J1400538 73J1400133 01A1400226
73J1400547 73K1400464 01A1400432
73K1400341 73K1400465
01B1400083 73K1400342 5-16128
73L1400012 01B1400356 73K1400343
73K1400582 01B1400357 73K1400462
73L1400233 01C1400260 73L1400098
73A1500039 73D1400097
73L1400234 5-16135 73A1500040
73E1400504 73L1400235 73B1500259
73F1400449 73L1400584 73B1500293
73G1400387 73L1400609 73C1500401
73G1400597 73M1400071 73C1500426
73H1400033 73M1400072 01K1300470
73H1400332 73M1400073 01B1400479
73J1400259 73M1400192 73D1400498
73J1400260 73M1400193 73F1400096
73J1400261 73A1500342 73H1400443
73K1400130 73A1500343 73J1400117
73K1400131 73A1500344 73K1400583
73K1400132 73A1500590 73L1400094
73K1400225 73A1500589 73A1500205
73K1400226 73B1500076 73A1500206
73K1400227 73B1500532
73B1500258 73L1400236 73C1500110
5-16137 73B1500354 73L1400382
73C1500111 73B1500355 73L1400383
73C1500531 73C1500402 73L1400384
73C1500532 73C1500427
73L1400489 73C1500582 5-16139
73G1400177 73L1400583 73D1500096
73H1400444 73L1400608 73D1500097
73L1400095 73A1500481
73D1500098 73A1500041 73A1500482
5-16039 01K1300469
73A1500203 73B1500077 01L1300082
5-16141 01L1300156 73B1500078
01L1300083 01A1400452 73B1500353
01L1300559 73G1400178 73B1500529
01M1300214 73G1400510 73B1500530
01A1400227 73H1400009 73B1500531
01A1400576 73K1400553 73C1500256
01B1400243 73B1500257
73C1500257 01B1400478 5-16142
01J1300535 73C1500581 73C1400067
01M1300215 73D1500099
73D1400340 01A1400321
73D1400579
73E1400113
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150908005205/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024